Form 8-K - Current report:
SEC Accession No. 0001185185-24-000923
Filing Date
2024-09-27
Accepted
2024-09-27 16:05:14
Documents
15
Period of Report
2024-09-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igc20240926_8k.htm   iXBRL 8-K 30024
2 EXHIBIT 10.1 ex_727832.htm EX-10.1 104507
6 igc20240926_8kimg001.jpg GRAPHIC 2039
  Complete submission text file 0001185185-24-000923.txt   280159

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA igc-20240925.xsd EX-101.SCH 3016
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20240925_lab.xml EX-101.LAB 19979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20240925_pre.xml EX-101.PRE 10970
17 EXTRACTED XBRL INSTANCE DOCUMENT igc20240926_8k_htm.xml XML 2726
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 241334859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)